{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:57:24Z","timestamp":1792807044440,"version":"4.5.0"},"reference-count":400,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Postgraduate Research, University of the Free State, Bloemfontein South Africa","award":["1-459-33279-1831"],"award-info":[{"award-number":["1-459-33279-1831"]}],"id":[{"id":"https:\/\/ror.org\/009xwd568","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Safety, efficacy, and cost-effectiveness are paramount to vaccine development. Following the isolation of rotavirus particles in 1969 and its evidence as an aetiology of severe dehydrating diarrhoea in infants and young children worldwide, the quest to find not only an acceptable and reliable but cost-effective vaccine has continued until now. Four live-attenuated oral rotavirus vaccines (LAORoVs) (Rotarix\u00ae, RotaTeq\u00ae, Rotavac\u00ae, and RotaSIIL\u00ae) have been developed and licensed to be used against all forms of rotavirus-associated infection. The efficacy of these vaccines is more obvious in the high-income countries (HIC) compared with the low- to middle-income countries (LMICs); however, the impact is far exceeding in the low-income countries (LICs). Despite the rotavirus vaccine efficacy and effectiveness, more than 90 countries (mostly Asia, America, and Europe) are yet to implement any of these vaccines. Implementation of these vaccines has continued to suffer a setback in these countries due to the vaccine cost, policy, discharging of strategic preventive measures, and infrastructures. This review reappraises the impacts and effectiveness of the current live-attenuated oral rotavirus vaccines from many representative countries of the globe. It examines the problems associated with the low efficacy of these vaccines and the way forward. Lastly, forefront efforts put forward to develop initial procedures for oral rotavirus vaccines were examined and re-connected to today vaccines.<\/jats:p>","DOI":"10.3390\/vaccines8030341","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T05:28:56Z","timestamp":1593408536000},"page":"341","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines"],"prefix":"10.3390","volume":"8","author":[{"given":"Olufemi Samuel","family":"Folorunso","sequence":"first","affiliation":[{"name":"Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, PO Box 339, Bloemfontein 9300, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-1084","authenticated-orcid":false,"given":"Olihile M.","family":"Sebolai","sequence":"additional","affiliation":[{"name":"Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, PO Box 339, Bloemfontein 9300, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1093\/nar\/14.8.3215","article-title":"The stiffness of dsRNA: Hydrodynamic studies on fluorescence-labelled RNA segments of bovine rotavirus","volume":"14","author":"Kapahnke","year":"1986","journal-title":"Nucleic Acids Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1099\/0022-1317-75-12-3423","article-title":"Identification of the nucleic acid binding domain of the rotavirus VP2 protein","volume":"75","author":"Labbe","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1073\/pnas.92.7.2662","article-title":"Adherence to the First-Aug Rule When a Second Aug Codon Follows Closely Upon the First","volume":"92","author":"Kozak","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)60858-1","article-title":"Molecular biology of rotaviruses","volume":"38","author":"Bellamy","year":"1990","journal-title":"Advances in Virus Research"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Estes, M.K., and Cohen, J. (1989). Rota gene structure and function. Microbiol. Rev., 410\u2013449.","DOI":"10.1128\/mr.53.4.410-449.1989"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0042-6822(91)90495-W","article-title":"Expression of rotavirus proteins encoded by alternative open reading frames of genome segment 11","volume":"181","author":"Mattion","year":"1991","journal-title":"Virology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0042-6822(89)90614-4","article-title":"Sequences of VP9 genes from short and supershort rotavirus strains","volume":"171","author":"Nuttall","year":"1989","journal-title":"Virology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/382471a0","article-title":"Visualization of ordered genomic RNA and localization of transcriptional complexes in rotavirus","volume":"382","author":"Prasad","year":"1996","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00705-008-0155-1","article-title":"Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments","volume":"153","author":"Matthijnssens","year":"2008","journal-title":"Arch. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3201\/eid2104.141370","article-title":"Candidate New Rotavirus Species in Sheltered Dogs, Hungary","volume":"21","author":"Gellert","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_11","first-page":"19","article-title":"Candidate new rotavirus species in Schreiber\u2019s bats, Serbia","volume":"48","author":"Banyai","year":"2017","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis."},{"key":"ref_12","unstructured":"Knipe, P.M., and Howley, D.M. (2013). Rotavirus. Fields Virology, Wolters Kluwer Health\/Lippincott Williams & Wilkins."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virusres.2003.12.007","article-title":"Emerging themes in rotavirus cell entry, genome organization, transcription and replication","volume":"101","author":"Jayaram","year":"2004","journal-title":"Virus Res."},{"key":"ref_14","unstructured":"World Health Organisation (WHO) (2018). Immunization, Vaccines and Biologicals-Rotavirus, WHO."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Collaborators","year":"2018","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","article-title":"2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis","volume":"12","author":"Tate","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr."},{"key":"ref_18","first-page":"170","article-title":"Genotype of Rotavirus Vaccine Strain LLR in China is G10P[15]","volume":"31","author":"Li","year":"2015","journal-title":"Bing Du Xue Bao Chin. J. Virol."},{"key":"ref_19","first-page":"43","article-title":"Advances in research on Rotavin-M1","volume":"59","author":"Le","year":"2017","journal-title":"Vietnam J. Sci. Technol. Eng."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/INF.0b013e3182a72fc0","article-title":"Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization After Introduction Into the South African Public Immunization Program","volume":"32","author":"Msimang","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1056\/NEJMc1100062","article-title":"Childhood diarrhea deaths after rotavirus vaccination in Mexico","volume":"365","author":"Richardson","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.vaccine.2019.03.047","article-title":"Evidence of reduction of rotavirus diarrheal disease after rotavirus vaccine introduction in national immunization programs in the African countries: Report of the 11(th) African rotavirus symposium held in Lilongwe, Malawi","volume":"37","author":"Mwenda","year":"2019","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e01246-17","DOI":"10.1128\/JVI.01246-17","article-title":"Emergence of Double- and Triple-Gene Reassortant G1P[8] Rotaviruses Possessing a DS-1-Like Backbone after Rotavirus Vaccine Introduction in Malawi","volume":"92","author":"Jere","year":"2018","journal-title":"J. Virol."},{"key":"ref_24","first-page":"145","article-title":"Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: Causes and contributing factors","volume":"17","author":"Velasquez","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/cid\/civ828","article-title":"Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants","volume":"62","author":"Moon","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/INF.0000000000000481","article-title":"Rotavirus-specific IgG antibodies from mothers\u2019 serum may inhibit infant immune responses to the pentavalent rotavirus vaccine","volume":"34","author":"Vilchez","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virusres.2012.04.001","article-title":"Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells","volume":"167","author":"Wang","year":"2012","journal-title":"Virus Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/infdis\/jiw518","article-title":"Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana","volume":"215","author":"Harris","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/19490976.2017.1376162","article-title":"Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan","volume":"9","author":"Harris","year":"2018","journal-title":"Gut Microbes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.it.2014.07.003","article-title":"Influence of the microbiota on vaccine effectiveness","volume":"35","author":"Valdez","year":"2014","journal-title":"Trends Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1053\/j.gastro.2009.02.076","article-title":"Rotaviruses: From pathogenesis to vaccination","volume":"136","author":"Greenberg","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_32","first-page":"213","article-title":"Prevention of rotavirus gastroenteritis in infants and children: Rotavirus vaccine safety, efficacy, and potential impact of vaccines","volume":"4","author":"Chandran","year":"2010","journal-title":"Biologics"},{"key":"ref_33","unstructured":"World Health Organisation (2019). Immunization Coverage, WHO."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000\u20132013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","unstructured":"RotaCouncil (2020). Global Introduction Status-Rotavirus vaccine Introduction and Coverage, Johns Hopkins Bloomberg School of Public Health and International Vacccine Access Center (IVAC)."},{"key":"ref_36","unstructured":"Sabin Vaccine Institute (2018, January 29\u201330). Expanding Rotavirus Vaccine Impact: Improving Coverage and Equity. Proceedings of the 13th International Rotavirus Symposium, Minsk, Belarus."},{"key":"ref_37","unstructured":"United Nations Children\u2019s Fund (UNICEF) (2018). Vaccine Resourse Library, PATH."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40272-018-0283-3","article-title":"Rotavirus Vaccines: Effectiveness, Safety, and Future Directions","volume":"20","author":"Burnett","year":"2018","journal-title":"Paediatr. Drugs"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/14760584.2018.1443008","article-title":"Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children < 5 in Asia","volume":"17","author":"Burnett","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_40","unstructured":"World Health Organisation (WHO) (2009). State of the World\u2019s Vaccines and Immunizations, WHO."},{"key":"ref_41","unstructured":"Global Alliance for Vaccines and Immunizations (GAVI) (2018). Gavi Supports Rotavirus Vaccine Introduction in Uganda, GAVI."},{"key":"ref_42","unstructured":"United Nation Children\u2019s Fund (UNICEF) (2016). Supply of Children\u2019s Five-in-One Vaccine Secured at Lowest-Ever Price, UNICEF."},{"key":"ref_43","unstructured":"GlaxoSmithKline (GSK) (2011). Millions of Children in the World\u2019s Poorest Countries could Receive Vaccination Against Rotavirus Diarrhoeal Disease under New Offer made by GSK to the GAVI Alliance, GlaxoSmithKline."},{"key":"ref_44","unstructured":"Merck & Co. Inc. (2011). Merck Commends GAVI Alliance on Continued Efforts to IMPROVE access, Merck & Co. Inc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7196\/SAMJ.7597","article-title":"Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme","volume":"104","author":"Madhi","year":"2014","journal-title":"Samj S. Afr. Med. J."},{"key":"ref_46","unstructured":"United Nations Children\u2019s Fund (UNICEF) (2019). Supplies and Logistics. Vaccine Price Data, UNICEF."},{"key":"ref_47","unstructured":"Centers for Disease Control Prevention (CDC) (2020). Vaccines for Children Program (VFC), National Center for Immunization and Respiratory Diseases."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ngabo, F., Mvundura, M., Gazley, L., Gatera, M., Rugambwa, C., Kayonga, E., Tuyishime, Y., Niyibaho, J., Mwenda, J.M., and Donnen, P. (2016). The economic burden attributable to a child\u2019s inpatient admission for diarrheal disease in Rwanda. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149805"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.1016\/j.vaccine.2017.11.080","article-title":"Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031","volume":"36","author":"Nonvignon","year":"2018","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1016\/j.vaccine.2017.10.058","article-title":"Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan","volume":"36","author":"Anwari","year":"2018","journal-title":"Vaccine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S1020-49892007000300003","article-title":"Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries","volume":"21","author":"Rheingans","year":"2007","journal-title":"Revista Panamericana de Salud P\u00fablica"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1016\/j.vaccine.2010.03.004","article-title":"Potential epidemiological and economical impact of two rotavirus vaccines in Colombia","volume":"28","author":"Alvis","year":"2010","journal-title":"Vaccine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1016\/j.vaccine.2011.12.096","article-title":"Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011\u20132030","volume":"30","author":"Atherly","year":"2012","journal-title":"Vaccine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/605033","article-title":"Rotavirus Vaccination: Cost-Effectiveness and Impact on Child Mortality in Developing Countries","volume":"200","author":"Atherly","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1016\/j.vaccine.2018.10.068","article-title":"Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines","volume":"36","author":"Pecenka","year":"2018","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e01476-18","DOI":"10.1128\/JVI.01476-18","article-title":"Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States","volume":"93","author":"Ogden","year":"2018","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/j.vaccine.2017.05.064","article-title":"Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies","volume":"35","author":"Kassim","year":"2017","journal-title":"Vaccine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: A randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"D55","DOI":"10.1016\/j.vaccine.2015.05.094","article-title":"Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines","volume":"33","author":"Parashar","year":"2015","journal-title":"Vaccine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/431512","article-title":"More on RotaShield and intussusception: The role of age at the time of vaccination","volume":"192","author":"Simonsen","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_64","unstructured":"Global Alliance for Vaccines and Immunizations (GAVI) (2018). The Vaccine Alliance Risk and Assurance Report 2018. Risk & Assurance Report 2018, GAVI."},{"key":"ref_65","unstructured":"World Health Organisation (WHO) (2013). Introduction of rotavirus vaccines. Information for Policy Makers, Programme Managers, and Health Workers, Expanded Programme on Immunization of the Department of Immunization, Vaccines, and Biologicals."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0264-410X(93)90025-S","article-title":"Development of candidate rotavirus vaccines","volume":"11","author":"Bishop","year":"1993","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kapikian, A.Z., Flores, J., Midthun, K., Hoshino, Y., Green, K.Y., Gorziglia, M., Nishikawa, K., Chanock, R.M., Potash, L., and Perez-Schael, I. (1989). Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines. The Immune Response to Viral Infections, Springer.","DOI":"10.1007\/978-1-4684-5712-4_9"},{"key":"ref_68","unstructured":"Lobmann, M., Charlier, P., Delem, A., Zygraich, N., Lambert, J.P., and Zissis, G. (1981, January 2\u20137). Challenge experiments in colostrum deprived piglets previously immunized with human type 2 and bovine, RIT4237, rotavirus strains; evidence of homologous and heterologous protection. Proceedings of the Fifth International Congress of Virology, Strasbourg, France."},{"key":"ref_69","unstructured":"Lobmann, M., Charlier, P., Delem, A., Zygraich, N., Lambert, J.P., and Zissis, G. (1981, January 8\u201311). Cross-protection studies in piglets artificially infected with the bovine rotavirus strain RIT 4237, and challenged with human rotavirus type 2 and type 3. Proceedings of the Recent Advances in Enteric Infections, Brugge, Belgium."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/infdis\/148.6.1061","article-title":"Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge","volume":"148","author":"Zissis","year":"1983","journal-title":"J. Infect. Dis."},{"key":"ref_71","first-page":"69","article-title":"Cell culture propagation of neonatal calf diarrhea (scours) virus","volume":"12","author":"Mebus","year":"1971","journal-title":"Can. Vet. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-1157(84)80068-2","article-title":"A bovine rotavirus developed as a candidate vaccine for use in humans","volume":"12","author":"Delem","year":"1984","journal-title":"J. Biol. Stand."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(83)90734-1","article-title":"Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children","volume":"322","author":"Vesikari","year":"1983","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(84)92323-7","article-title":"Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine","volume":"1","author":"Vesikari","year":"1984","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3476(86)80271-2","article-title":"Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants","volume":"109","author":"Maldonado","year":"1986","journal-title":"J. Pediatr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(87)90649-0","article-title":"Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants","volume":"1","author":"Hanlon","year":"1987","journal-title":"Lancet"},{"key":"ref_77","first-page":"108","article-title":"Failure of live, attenuated oral rotavirus vaccine","volume":"2","author":"Zissis","year":"1986","journal-title":"Lancet"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/jama.1995.03520390051032","article-title":"Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group","volume":"273","author":"Bernstein","year":"1995","journal-title":"JAMA"},{"key":"ref_79","first-page":"7","article-title":"Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines\u2014report of the National Multicenter Trial","volume":"97","author":"Rennels","year":"1996","journal-title":"Pediatrics"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006454-198601000-00005","article-title":"Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants","volume":"5","author":"Losonsky","year":"1986","journal-title":"Pediatr. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/159.4.753","article-title":"Prolonged efficacy of rhesus rotavirus vaccine in Swedish children","volume":"159","author":"Gothefors","year":"1989","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archpedi.1990.02150270035021","article-title":"Rhesus rotavirus candidate vaccine: Clinical trial in children vaccinated between 2 and 5 months of age","volume":"144","author":"Vesikari","year":"1990","journal-title":"Am. J. Dis. Child."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00006454-198809000-00009","article-title":"Field trial of rhesus rotavirus vaccine in infants","volume":"7","author":"Christy","year":"1988","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_84","first-page":"181","article-title":"Diploid cell lines from subhuman primates as substrates for virus vaccine production","volume":"5","author":"Wallace","year":"1971","journal-title":"Prog. Immunobiol. Stand."},{"key":"ref_85","unstructured":"Lerner, R.A., Chanock, R.M., and Brown, F. (1985). Rhesus rotavirus: A candidate vaccine for prevention of human rotavirus disease. Vaccines 85: Molecular and Chemical Basis of Resistance to Parasitic, Bacterial and Viral Diseases, Cold Spring Harbor Laboratory."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/153.5.832","article-title":"A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children","volume":"153","author":"Vesikari","year":"1986","journal-title":"J. Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1651-2227.1986.tb10253.x","article-title":"Oral rotavirus vaccination in breast-and bottle-fed infants aged 6 to 12 months","volume":"75","author":"Vesikari","year":"1986","journal-title":"Acta P\u00e6diatrica"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1126\/science.216077","article-title":"Rotaviral immunity in gnotobiotic calves: Heterologous resistance to human virus induced by bovine virus","volume":"203","author":"Wyatt","year":"1979","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/iai.14.3.804-810.1976","article-title":"Morphological and Antigenic Relationships between Viruses (Rotaviruses) from Acute Gastroenteritis of Children, Calves, Piglets, Mice, and Foals","volume":"14","author":"Woode","year":"1976","journal-title":"Infect. Immun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/clinids\/2.3.459","article-title":"Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses","volume":"2","author":"Kapikian","year":"1980","journal-title":"Rev. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/162.5.1055","article-title":"Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants","volume":"162","author":"Bernstein","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/infdis\/158.3.570","article-title":"Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season","volume":"158","author":"Clark","year":"1988","journal-title":"J. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/infdis\/162.6.1298","article-title":"Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection","volume":"162","author":"Ward","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_94","unstructured":"Fields, B.N., and Knipe, D.M. (1990). Rotaviruses. Virology, Raven Press Ltd."},{"key":"ref_95","first-page":"912","article-title":"Evaluation of the M37 human rotavirus vaccine in 2-to 6-month-old infants","volume":"10","author":"Vesikari","year":"1991","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/infdis\/164.4.792","article-title":"Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants","volume":"164","author":"Midthun","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0140-6736(90)91876-C","article-title":"Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine","volume":"336","author":"Flores","year":"1990","journal-title":"Lancet"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1754.1997.tb01604.x","article-title":"Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate","volume":"33","author":"Barnes","year":"1997","journal-title":"J. Paediatr. Child. Health"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJM198307143090203","article-title":"Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children","volume":"309","author":"Bishop","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/S0264-410X(02)00235-9","article-title":"Early phase II trial of human rotavirus vaccine candidate RV3","volume":"20","author":"Barnes","year":"2002","journal-title":"Vaccine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0966-842X(94)90629-7","article-title":"Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children","volume":"2","author":"Hoshino","year":"1994","journal-title":"Trends Microbiol."},{"key":"ref_102","unstructured":"Hoshino, Y., Kapikian, A.Z., and Chanock, R.M. (2006). Attenuated human rotavirus vaccine. (US7150984B2), U.S. Patent."},{"key":"ref_103","unstructured":"United States\u2014Department of State\u2014Bureau of Oceans\u2014International Environmental and Scientific Affairs (1990). The United States-Japan Cooperative Medical Science Program.: Fifth Five-year Report, 1986\u20131990, Bureau of Oceans and International Environmental and Scientific Affairs, University of Minnesota."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0168-1702(87)90033-5","article-title":"Cold-adaptation of human rotavirus","volume":"7","author":"Shigeo","year":"1987","journal-title":"Virus Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00006454-198708000-00002","article-title":"Perspective on the development and deployment of rotavirus vaccines","volume":"6","author":"Edelman","year":"1987","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/jvi.53.3.949-954.1985","article-title":"Reassortant rotaviruses as potential live rotavirus vaccine candidates","volume":"53","author":"Midthun","year":"1985","journal-title":"J. Virol."},{"key":"ref_107","unstructured":"Holmgren, J., Lindberg, A., and Mollby, R. (1986). Alternative approaches to the development of a rotavirus vaccine. Development of Vaccines and Drugs Against Diarrhoea: 11th Nobel Conference, Stockholm, 1985, Student Litteratur."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006454-199207000-00006","article-title":"Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity","volume":"11","author":"Vesikari","year":"1992","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/jcm.27.3.512-518.1989","article-title":"Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants","volume":"27","author":"Flores","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/jcm.28.3.553-558.1990","article-title":"Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants","volume":"28","author":"Blanco","year":"1990","journal-title":"J. Clin. Microbiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/jvi.64.1.361-368.1990","article-title":"Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus","volume":"64","author":"Uhnoo","year":"1990","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0264-410X(90)90089-5","article-title":"Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants","volume":"8","author":"Clark","year":"1990","journal-title":"Vaccine"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/CMR.9.3.423","article-title":"Rotavirus vaccines: An overview","volume":"9","author":"Midthun","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/infdis\/163.3.483","article-title":"A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population","volume":"163","author":"Santosham","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_115","first-page":"429","article-title":"The present status of rotavirus vaccine development","volume":"19","author":"Bishop","year":"1988","journal-title":"Southeast. Asian J. Trop. Med. Public Health"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/514076","article-title":"Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group","volume":"176","author":"Ward","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1086\/367895","article-title":"Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions","volume":"187","author":"Murphy","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/infdis\/174.Supplement_1.S73","article-title":"The Development of Multivalent Bovine Rotavirus (Strain WC3) Reassortant","volume":"174","author":"Clark","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/cid\/civ872","article-title":"Long-term consistency in rotavirus vaccine protection: RV5 and RV1 vaccine effectiveness in US children, 2012\u20132013","volume":"61","author":"Payne","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"G72","DOI":"10.1016\/j.vaccine.2009.09.107","article-title":"Development of a rotavirus vaccine: Clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq\u00ae","volume":"27","author":"Ciarlet","year":"2009","journal-title":"Vaccine"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2009.10.041","article-title":"RotaTeq\u00ae, a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe","volume":"28","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","article-title":"Rotavirus infection in infants as protection against subsequent infections","volume":"335","author":"Velazquez","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human\u2013bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_124","unstructured":"Vesikari, T., Karvonen, A., Prymula, R., Schuster, V., Tejedor, J.C., Cohen, R., Damaso, S., Han, H.H., De Vos, B., and Meurice, F. (2006, January 3\u20135). Human rotavirus vaccine RotarixTM (RIX4414) is highly efficacious in Europe. Proceedings of the 24th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Basel, Switzerland."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.1016\/j.vaccine.2017.03.076","article-title":"The rotavirus vaccine development pipeline","volume":"37","author":"Kirkwood","year":"2019","journal-title":"Vaccine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1473-3099(19)30126-4","article-title":"Efficacy of live oral rotavirus vaccines by duration of follow-up: A meta-regression of randomised controlled trials","volume":"19","author":"Clark","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Velazquez","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/INF.0000000000000683","article-title":"European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: Update 2014","volume":"34","author":"Vesikari","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cid\/cit164","article-title":"Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009\u20132011","volume":"57","author":"Payne","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_130","first-page":"108","article-title":"Research Article (New England Journal of Medicine) Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"28","author":"Madhi","year":"2016","journal-title":"Malawi Med. J."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Zaman, K., Sack, D.A., Neuzil, K.M., Yunus, M., Moulton, L.H., Sugimoto, J.D., Fleming, J.A., Hossain, I., Arifeen, S.E., and Azim, T. (2017). Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002282"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00431-010-1242-3","article-title":"Efficacy of the pentavalent rotavirus vaccine, RotaTeq\u00ae, in Finnish infants up to 3 years of age: The Finnish Extension Study","volume":"169","author":"Vesikari","year":"2010","journal-title":"Eur. J. Pediatr."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: Randomised, double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/cid\/civ1183","article-title":"Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses","volume":"62","author":"Jere","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/j.vaccine.2017.10.050","article-title":"Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa","volume":"36","author":"Weldegebriel","year":"2018","journal-title":"Vaccine"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1016\/j.vaccine.2018.06.026","article-title":"Impact of rotavirus vaccines in Sub-Saharan African countries","volume":"36","author":"Mwenda","year":"2018","journal-title":"Vaccine"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.vaccine.2015.03.016","article-title":"Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014","volume":"33","author":"Karafillakis","year":"2015","journal-title":"Vaccine"},{"key":"ref_141","unstructured":"International Vaccine Access Center (IVAC) (2019). Map Gallery-Rotavirus, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"E893","DOI":"10.1016\/S2214-109X(19)30207-4","article-title":"Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008\u20132016: Findings from the Global Rotavirus Surveillance Network","volume":"7","author":"Aliabadi","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1016\/S2214-109X(19)30232-3","article-title":"Monitoring the impact of rotavirus vaccines on a global scale","volume":"7","author":"McQuade","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cmi.2018.03.046","article-title":"Rotavirus vaccine effectiveness in preventing hospitalizations due to gastroenteritis: A descriptive epidemiological study from Germany","volume":"25","author":"Pietsch","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/infdis\/jir492","article-title":"Infant Rotavirus Vaccination May Provide Indirect Protection to Older Children and Adults in the United States","volume":"204","author":"Lopman","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cis1010","article-title":"Indirect protection of adults from rotavirus by pediatric rotavirus vaccination","volume":"56","author":"Anderson","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.vaccine.2011.01.104","article-title":"Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria","volume":"29","author":"Kundi","year":"2011","journal-title":"Vaccine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1093\/cid\/ciw045","article-title":"Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children","volume":"62","author":"Sahakyan","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_149","unstructured":"World Health Organization (WHO) (2013). The Global Vaccine Action Plan. (GVAP) 2011\u20132020, WHO."},{"key":"ref_150","unstructured":"World Health Organization (WHO), and United Nation Children\u2019s Fund (UNICEF) (2019). Progress Towards Global Immunisation Goals, 2018: Summary Presentation of Key Indicators, WHO."},{"key":"ref_151","unstructured":"World Health Organization (WHO), and United Nation Children\u2019s Fund (UNICEF) (2017). Change in vaccine vial monitor (VVM) assignment for GlaxoSmithKline Rotarix\u00ae Product, WHO."},{"key":"ref_152","unstructured":"Merck & Co. Inc. (2018). Merck Reaffirms Commitment to Increase Vaccine Production and Clarifies Rotavirus Vaccine Transition Plan with Gavi Countries, Merck & Co. Inc."},{"key":"ref_153","unstructured":"Global Alliance for Vaccines and Immunizations (GAVI) (2019). The Vacine Alliance Risks and Assurance Report 2019, GAVI."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/00365549009027046","article-title":"Rotavirus disease in Finnish children: Use of numerical scores for clinical severity of diarrhoeal episodes","volume":"22","author":"Ruuska","year":"1990","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(87)92858-3","article-title":"Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants","volume":"1","author":"Flores","year":"1987","journal-title":"Lancet"},{"key":"ref_156","first-page":"350","article-title":"Immune response of infants and children to low-passage bovine rotavirus (strain WC3)","volume":"140","author":"Clark","year":"1986","journal-title":"Am. J. Dis. Child."},{"key":"ref_157","first-page":"1","article-title":"Faecal shedding of rotavirus vaccine in Chinese children after vaccination with Lanzhou lamb rotavirus vaccine","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vaccine.2012.10.078","article-title":"Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children","volume":"31","author":"Fu","year":"2012","journal-title":"Vaccine"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/infdis\/jit174","article-title":"Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period","volume":"208","author":"Armah","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.inf.0000199288.98370.71","article-title":"Neonatal administration of rhesus rotavirus tetravalent vaccine","volume":"25","author":"Vesikari","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00148581-200608030-00008","article-title":"Rotavirus vaccine (RotaTeq)","volume":"8","author":"Keating","year":"2006","journal-title":"Paediatr. Drugs"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/INF.0b013e31825d611e","article-title":"Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis","volume":"31","author":"Hemming","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/INF.0000000000000579","article-title":"Detection of vaccine-derived rotavirus strains in nonimmunocompromised children up to 3\u20136 months after RotaTeq\u00ae vaccination","volume":"34","author":"Markkula","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/j.vaccine.2011.08.124","article-title":"Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine","volume":"30","author":"Breiman","year":"2012","journal-title":"Vaccine"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/505151","article-title":"Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and Rhesus\u2013Rhesus-Human rotavirus reassortant tetravalent vaccines in Finnish children","volume":"194","author":"Vesikari","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.vaccine.2017.04.025","article-title":"Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL\u00ae)","volume":"35","author":"Naik","year":"2017","journal-title":"Vaccine"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/CMR.00029-07","article-title":"Rotavirus vaccines: An overview","volume":"21","author":"Dennehy","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.inf.0000164763.55558.71","article-title":"Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine","volume":"24","author":"Dennehy","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1586\/14760584.6.1.11","article-title":"Rotarix\u2122(RIX4414): An oral human rotavirus vaccine","volume":"6","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"ref_170","first-page":"245","article-title":"Rotavirus vaccines at the threshold of implementation in India","volume":"27","author":"Tate","year":"2014","journal-title":"Natl. Med. J. India"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/j.vaccine.2013.04.008","article-title":"Phase I trial of RV3-BB rotavirus vaccine: A human neonatal rotavirus vaccine","volume":"31","author":"Danchin","year":"2013","journal-title":"Vaccine"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1473-3099(15)00227-3","article-title":"Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: A randomised, double-blind, placebo-controlled trial","volume":"15","author":"Bines","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1706804","article-title":"Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth","volume":"378","author":"Bines","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2005.07.030","article-title":"A short report on the highlights of world-wide development of RIX4414: A North American experience comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine (RIX4414) in infants in the United States and Canada","volume":"24","author":"Dennehy","year":"2006","journal-title":"Vaccine"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.vaccine.2015.06.058","article-title":"Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries","volume":"33","author":"Parashar","year":"2015","journal-title":"Vaccine"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"f3726","DOI":"10.1136\/bmj.f3726","article-title":"Effectiveness of monovalent rotavirus vaccine in Bolivia: Case-control study","volume":"346","author":"Patel","year":"2013","journal-title":"BMJ"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"C99","DOI":"10.1016\/j.vaccine.2013.05.065","article-title":"Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries","volume":"31","author":"Giglio","year":"2013","journal-title":"Vaccine"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1542\/peds.2011-3478","article-title":"Duration of protection of pentavalent rotavirus vaccination in Nicaragua","volume":"130","author":"Patel","year":"2012","journal-title":"Pediatrics"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1016\/j.vaccine.2011.09.120","article-title":"Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial","volume":"30","author":"Cunliffe","year":"2012","journal-title":"Vaccine"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Steele, A.D., Neuzil, K.M., Cunliffe, N.A., Madhi, S.A., Bos, P., Ngwira, B., Witte, D., Todd, S., Louw, C., and Kirsten, M. (2012). Human rotavirus vaccine Rotarix\u2122 provides protection against diverse circulating rotavirus strains in African infants: A randomized controlled trial. BMC Infect. Dis., 12.","DOI":"10.1186\/1471-2334-12-213"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QCO.0000000000000572","article-title":"Current and new rotavirus vaccines","volume":"32","author":"Burke","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger","volume":"376","author":"Isanaka","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"A110","DOI":"10.1016\/j.vaccine.2014.04.079","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life","volume":"32","author":"Bhandari","year":"2014","journal-title":"Vaccine"},{"key":"ref_184","unstructured":"Dadonaite, B., and Ritchie, H. (2019). Rotavirus vaccine \u2013 An effective tool that prevents children dying from diarrhea. Our World in Data, Global Change Data Lab (GCDL)."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/INF.0b013e3181e28e6e","article-title":"Sustained Efficacy of the Pentavalent Rotavirus Vaccine, RV5, up to 3.1 Years Following the Last Dose of Vaccine","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1542\/peds.2010-3722","article-title":"Effectiveness of pentavalent rotavirus vaccine against severe disease","volume":"128","author":"Staat","year":"2011","journal-title":"Pediatrics"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1097\/INF.0b013e31822a8527","article-title":"Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua","volume":"30","author":"Mast","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2014.01.007","article-title":"Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study","volume":"32","author":"Ichihara","year":"2014","journal-title":"Vaccine"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1016\/j.vaccine.2017.10.027","article-title":"Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality","volume":"35","author":"Burnett","year":"2017","journal-title":"Vaccine"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/apa.14697","article-title":"Rotavirus vaccine for neonates","volume":"108","author":"Hodgson","year":"2019","journal-title":"Acta Paediatr."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0264-410X(02)00615-1","article-title":"Anticipating rotavirus vaccines: Epidemiology and surveillance of rotavirus in South Africa","volume":"21","author":"Steele","year":"2003","journal-title":"Vaccine"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1016\/j.vaccine.2011.08.080","article-title":"Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial","volume":"30","author":"Madhi","year":"2012","journal-title":"Vaccine"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mi.2014.114","article-title":"Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings","volume":"8","author":"Clarke","year":"2015","journal-title":"Mucosal. Immunol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Lopman, B.A., Pitzer, V.E., Sarkar, R., Gladstone, B., Patel, M., Glasser, J., Gambhir, M., Atchison, C., Grenfell, B.T., and Edmunds, W.J. (2012). Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041720"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004300050049","article-title":"Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29","volume":"186","author":"Superti","year":"1997","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(97)10322-1","article-title":"Role of human-milk lactadherin in protectoin against symptomatic rotavirus infection","volume":"351","author":"Newburg","year":"1998","journal-title":"Lancet"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1172\/JCI116078","article-title":"Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis","volume":"90","author":"Yolken","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/INF.0b013e3181e232ea","article-title":"Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines","volume":"29","author":"Moon","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/INF.0b013e318290646d","article-title":"Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries","volume":"32","author":"Moon","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2471\/BLT.13.128066","article-title":"Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: A randomized trial in HIV-uninfected infants in Soweto, South Africa","volume":"92","author":"Groome","year":"2014","journal-title":"Bull. World Health Organ."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Ali, A., Kazi, A.M., Cortese, M.M., Fleming, J.A., Moon, S., Parashar, U.D., Jiang, B., McNeal, M.M., Steele, D., and Bhutta, Z. (2015). Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine\u2014A randomized trial. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145568"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"A134","DOI":"10.1016\/j.vaccine.2014.04.078","article-title":"Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants","volume":"32","author":"Strand","year":"2014","journal-title":"Vaccine"},{"key":"ref_203","first-page":"6","article-title":"Impact of with-holding breastfeeding around the time of vaccination on the immunogenicity of the human rotavirus vaccine in Pakistan\u2014A randomized controlled trial","volume":"11","author":"Ali","year":"2013","journal-title":"Vaccines Enteric Dis."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/cid\/civ1207","article-title":"Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: A multisite prospective case-control study","volume":"62","author":"Steenhoff","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/INF.0b013e318168d29e","article-title":"Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency","volume":"27","author":"Goveia","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1542\/peds.96.6.1132","article-title":"Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group","volume":"96","author":"Rennels","year":"1995","journal-title":"Pediatrics"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/162.3.753","article-title":"Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: A metaanalysis","volume":"162","author":"Pichichero","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.vaccine.2013.12.017","article-title":"Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants","volume":"32","author":"Appaiahgari","year":"2014","journal-title":"Vaccine"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/jcm.29.12.2856-2859.1991","article-title":"Antibodies to seven rotavirus serotypes in cord sera, maternal sera, and colostrum of German women","volume":"29","author":"Brussow","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/jcm.12.3.320-325.1980","article-title":"Transfer of antirotaviral antibodies from mothers to their infants","volume":"12","author":"McLean","year":"1980","journal-title":"J. Clin. Microbiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/bmj.2.6099.1390","article-title":"Rotavirus neutralisation by human milk","volume":"2","author":"Thouless","year":"1977","journal-title":"Br. Med. J."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jmv.1890110211","article-title":"Studies on human lacteal rotavirus antibodies by immune electron microscopy","volume":"11","author":"Totterdell","year":"1983","journal-title":"J. Med. Virol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/infdis\/158.2.477","article-title":"Serotype-specific antibodies to rotavirus in human colostrum and breast milk and in maternal and cord blood","volume":"158","author":"Ringenbergs","year":"1988","journal-title":"J. Infect. Dis."},{"key":"ref_214","first-page":"186","article-title":"Prevalence of Neutralizing Antibodies against Different Rotavirus Serotypes in Children with Severe Rotavirus-Induced Diarrhea and Their Mothers","volume":"11","author":"Ray","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nature06245","article-title":"An ecological and evolutionary perspective on human-microbe mutualism and disease","volume":"449","author":"Dethlefsen","year":"2007","journal-title":"Nature"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Lin, A., Bik, E.M., Costello, E.K., Dethlefsen, L., Haque, R., Relman, D.A., and Singh, U. (2013). Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053838"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"20140144","DOI":"10.1098\/rstb.2014.0144","article-title":"Probiotics, antibiotics and the immune responses to vaccines","volume":"370","author":"Praharaj","year":"2015","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13099-016-0136-y","article-title":"Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs","volume":"8","author":"Twitchell","year":"2016","journal-title":"Gut Pathog."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Vlasova, A.N., Chattha, K.S., Kandasamy, S., Liu, Z., Esseili, M., Shao, L., Rajashekara, G., and Saif, L.J. (2013). Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076962"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/MPG.0b013e3182a356e1","article-title":"Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs","volume":"57","author":"Liu","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4161\/19490976.2014.969972","article-title":"Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model","volume":"5","author":"Kandasamy","year":"2014","journal-title":"Gut Microbes"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Mao, X., Gu, C., Hu, H., Tang, J., Chen, D., Yu, B., He, J., Yu, J., Luo, J., and Tian, G. (2016). Dietary Lactobacillus rhamnosus GG supplementation improves the mucosal barrier function in the intestine of weaned piglets challenged by porcine rotavirus. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146312"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vaccine.2017.11.031","article-title":"Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India","volume":"36","author":"Parker","year":"2018","journal-title":"Vaccine"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vaccine.2017.07.116","article-title":"The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants","volume":"36","author":"Lazarus","year":"2018","journal-title":"Vaccine"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4161\/hv.5.6.8176","article-title":"Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants","volume":"5","author":"Narang","year":"2009","journal-title":"Hum. Vaccines"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1093\/cid\/ciu611","article-title":"Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: Methods and challenges","volume":"59","author":"Hoest","year":"2014","journal-title":"Clin. Infect. Dis"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"20140141","DOI":"10.1098\/rstb.2014.0141","article-title":"Malnutrition and vaccination in developing countries","volume":"370","author":"Prendergast","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Khagayi, S., Omore, R., Otieno, G., Ogwel, B., Ochieng, J., Juma, J., Apondi, E., Bigogo, G., Onyango, C., and Ngama, M. (2019). Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.","DOI":"10.1093\/cid\/ciz664"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy1096","article-title":"Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe","volume":"69","author":"Mujuru","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/S0036-46652002000100003","article-title":"Nutritional status in relation to the efficacy of the rhesus-human reassortant, tetravalent rotavirus vaccine (RRV-TV) in infants from Belem, para state, Brazil","volume":"44","author":"Linhares","year":"2002","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1086\/519687","article-title":"Efficacy of the human rotavirus vaccine RIX4414 in malnourished children","volume":"196","author":"Salinas","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Steele, A.D., and Groome, M.J. (2019). Measuring Rotavirus Vaccine Impact in Sub-Saharan Africa. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciz918"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.vaccine.2016.04.080","article-title":"Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants","volume":"34","author":"Taniuchi","year":"2016","journal-title":"Vaccine"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/aje\/kws220","article-title":"Synergistic effects between rotavirus and coinfecting pathogens on diarrheal disease: Evidence from a community-based study in northwestern Ecuador","volume":"176","author":"Bhavnani","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10096-008-0641-0","article-title":"Rotavirus infection increases the risk of bacteremia in children with nontyphoid Salmonella gastroenteritis","volume":"28","author":"Hung","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.kjms.2012.04.025","article-title":"Salmonella\/rotavirus coinfection in hospitalized children","volume":"28","author":"Lee","year":"2012","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10096-013-1825-9","article-title":"Coinfection in acute gastroenteritis predicts a more severe clinical course in children","volume":"32","author":"Valentini","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.2009.756","article-title":"Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in Nicaragua","volume":"301","author":"Patel","year":"2009","journal-title":"JAMA"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1093\/cid\/civ1026","article-title":"Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013\u20132014","volume":"62","author":"Pringle","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/INF.0b013e3181ed18ab","article-title":"Sustained Protection from Pentavalent Rotavirus Vaccination during the Second Year of Life at a Large, Urban United States Pediatric Hospital","volume":"29","author":"Boom","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/649843","article-title":"Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil","volume":"201","author":"Correia","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1093\/cid\/civ1209","article-title":"Impact of Rotavirus Vaccine Introduction and Vaccine Effectiveness in the Republic of Moldova","volume":"62","author":"Gheorghita","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.vaccine.2011.11.071","article-title":"Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain","volume":"30","author":"Castilla","year":"2012","journal-title":"Vaccine"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1542\/peds.2012-3804","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccine","volume":"132","author":"Cortese","year":"2013","journal-title":"Pediatrics"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"c2825","DOI":"10.1136\/bmj.c2825","article-title":"Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: Case-control study","volume":"340","author":"Cruz","year":"2010","journal-title":"BMJ"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2014.03.064","article-title":"Effectiveness of the monovalent rotavirus vaccine in Colombia: A case-control study","volume":"32","author":"Parashar","year":"2014","journal-title":"Vaccine"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1093\/cid\/civ1012","article-title":"Real-world effectiveness of pentavalent rotavirus vaccine among Bedouin and Jewish children in southern Israel","volume":"62","author":"Leshem","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1016\/j.vaccine.2017.12.056","article-title":"Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso","volume":"36","author":"Bonkoungou","year":"2018","journal-title":"Vaccine"},{"key":"ref_250","unstructured":"World Health Organization (WHO) (2009). Rotavirus vaccines: An update. Weekly Epidemiological Record Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire, 84, 533\u2013537."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Patel, M.M., Clark, A.D., Sanderson, C.F.B., Tate, J., and Parashar, U.D. (2012). Removing the age restrictions for rotavirus vaccination: A benefit-risk modeling analysis. PLoS Med., 9.","DOI":"10.1371\/journal.pmed.1001330"},{"key":"ref_252","unstructured":"World Health Organization (WHO) (2012). Meeting of the Strategic Advisory Group of Experts on Immunization, April 2012\u2014conclusions and recommendations. Weekly Epidemiological Record Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire, 87, 201\u2013216."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.vaccine.2013.04.001","article-title":"Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria","volume":"31","author":"Kollaritsch","year":"2013","journal-title":"Vaccine"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Zlamy, M., Kofler, S., Orth, D., W\u00fcrzner, R., Heinz-Erian, P., Streng, A., and Prelog, M. (2013). The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-112"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.vaccine.2004.01.044","article-title":"Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants","volume":"22","author":"Vesikari","year":"2004","journal-title":"Vaccine"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S1473-3099(15)00295-9","article-title":"Neonatal rotavirus vaccination making headway","volume":"15","author":"Vesikari","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/00365549009027047","article-title":"Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: Correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period","volume":"22","author":"Ruuska","year":"1990","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-3476(85)80123-2","article-title":"Clinical Efficacy of the Rit-4237 Live Attenuated Bovine Rotavirus Vaccine in Infants Vaccinated before a Rotavirus Epidemic","volume":"107","author":"Vesikari","year":"1985","journal-title":"J. Pediatr."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jmv.1890210306","article-title":"Detection of serum antibody responses to RIT 4237 rotavirus vaccine by ELISA and neutralization assays","volume":"21","author":"Delem","year":"1987","journal-title":"J. Med. Virol."},{"key":"ref_260","first-page":"20143085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc. Biol. Sci."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/315051","article-title":"Effect of Small Bowel Bacterial Overgrowth on the Immunogenicity of Single-Dose Live Oral Cholera Vaccine CVD 103-HgR","volume":"180","author":"Lagos","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0016-5085(84)90606-1","article-title":"Intestinal flora in health and disease","volume":"86","author":"Simon","year":"1984","journal-title":"Gastroenterology"},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/tropej\/30.4.204","article-title":"Tropical enteropathy (environmental enteropathy) in early childhood: A syndrome caused by contaminated environment","volume":"30","author":"Viaro","year":"1984","journal-title":"J. Trop. Pediatr."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/07315724.1994.10718371","article-title":"Asymptomatic environmental enteropathy among slum-dwelling infants","volume":"13","author":"Neto","year":"1994","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.molmed.2012.04.007","article-title":"Environmental enteropathy: Critical implications of a poorly understood condition","volume":"18","author":"Korpe","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ebiom.2015.09.036","article-title":"Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh","volume":"2","author":"Naylor","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"Ferrante","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4269\/ajtmh.2012.12-0549","article-title":"Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants","volume":"88","author":"Kosek","year":"2013","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1203\/01.PDR.0000076666.16021.5E","article-title":"Chronic T cell-mediated enteropathy in rural west African children: Relationship with nutritional status and small bowel function","volume":"54","author":"Campbell","year":"2003","journal-title":"Pediatr. Res."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/jn\/133.5.1332","article-title":"Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation","volume":"133","author":"Campbell","year":"2003","journal-title":"J. Nutr."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/INF.0b013e3181f87ffe","article-title":"Changes in childhood diarrhea incidence in nicaragua following 3 years of universal infant rotavirus immunization","volume":"30","author":"Paniagua","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"41R","DOI":"10.1093\/glycob\/cwg054","article-title":"Fucose: Biosynthesis and biological function in mammals","volume":"13","author":"Becker","year":"2003","journal-title":"Glycobiology"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virol.2016.05.010","article-title":"Binding specificity of P[8] VP8* proteins of rotavirus vaccine strains with histo-blood group antigens","volume":"495","author":"Sun","year":"2016","journal-title":"Virology"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1038\/emi.2017.30","article-title":"Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy","volume":"6","author":"Jiang","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature10996","article-title":"Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen","volume":"485","author":"Hu","year":"2012","journal-title":"Nature"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/JVI.05507-11","article-title":"Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner","volume":"86","author":"Huang","year":"2012","journal-title":"J. Virol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1128\/JVI.01494-16","article-title":"Glycan Specificity of P[19] Rotavirus and Comparison with Those of Related P Genotypes","volume":"90","author":"Liu","year":"2016","journal-title":"J. Virol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.1128\/JVI.00979-12","article-title":"Rotavirus VP8*: Phylogeny, Host Range, and Interaction with Histo-Blood Group Antigens","volume":"86","author":"Liu","year":"2012","journal-title":"J. Virol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/cid\/ciu633","article-title":"Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner","volume":"59","author":"Nordgren","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cid\/civ873","article-title":"Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis","volume":"62","author":"Kambhampati","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/infdis\/jiy054","article-title":"Histo\u2013Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy","volume":"217","author":"Lee","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/infdis\/jix028","article-title":"Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants","volume":"215","author":"Kazi","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"A30","DOI":"10.1016\/j.vaccine.2011.11.093","article-title":"Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines","volume":"30","author":"Patel","year":"2012","journal-title":"Vaccine"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cid\/civ807","article-title":"Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh","volume":"62","author":"Emperador","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/INF.0b013e3181782780","article-title":"Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine","volume":"27","author":"Ciarlet","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_286","unstructured":"Ciarlet, M., Sani-Grosso, R., Yuan, G., Liu, G., Liu, P.M., and Gottesdiener, K.M. (2007, January 2\u20134). Safety and immunogenicity of concomitant use of the pentavalent rotavirus vaccine (RotaTeq) and oral poliovirus vaccine (OPV). Proceedings of the 25th Annual Meeting of the European Society for Paediatric Infectious Diseases, Porto, Portugal."},{"key":"ref_287","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"58","author":"Cortese","year":"2009","journal-title":"Morb. Mortal. Weekly Rep. Recomm. Rep."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2008.12.059","article-title":"Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age","volume":"27","author":"Zaman","year":"2009","journal-title":"Vaccine"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/infdis\/jiw024","article-title":"Noninterference of rotavirus vaccine with measles-rubella vaccine at 9 months of age and improvements in antirotavirus immunity: A randomized trial","volume":"213","author":"Zaman","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/infdis\/jiy215","article-title":"Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants","volume":"218","author":"Haidara","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"e00302","DOI":"10.1016\/j.heliyon.2017.e00302","article-title":"ROTAVAC\u00ae does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial","volume":"3","author":"Chandola","year":"2017","journal-title":"Heliyon"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1016\/j.vaccine.2018.07.064","article-title":"Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL(R) with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine","volume":"36","author":"Desai","year":"2018","journal-title":"Vaccine"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"7943","DOI":"10.1016\/j.vaccine.2018.11.006","article-title":"A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"36","author":"Rathi","year":"2018","journal-title":"Vaccine"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1016\/j.vaccine.2008.08.034","article-title":"Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines","volume":"28","author":"Steele","year":"2010","journal-title":"Vaccine"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1016\/j.vaccine.2010.05.057","article-title":"Immunogenicity and safety of the human rotavirus vaccine Rotarix\u2122 co-administered with routine infant vaccines following the vaccination schedules in Europe","volume":"28","author":"Vesikari","year":"2010","journal-title":"Vaccine"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1542\/peds.2008-1059","article-title":"Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States","volume":"122","author":"Dennehy","year":"2008","journal-title":"Pediatrics"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.inf.0000254391.71103.e8","article-title":"Concomitant Use of an Oral Live Pentavalent Human-Bovine Reassortant Rotavirus Vaccine With Licensed Parenteral Pediatric Vaccines in the United States","volume":"26","author":"Rodriguez","year":"2007","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_298","first-page":"892","article-title":"Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine","volume":"145","author":"Ing","year":"1991","journal-title":"Am. J. Dis. Child."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/infdis\/173.2.306","article-title":"Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: Effects on immune responses to both vaccines and on efficacy of rotavirus vaccines","volume":"173","author":"Rennels","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0264-410X(95)93131-R","article-title":"Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants","volume":"13","author":"Migasena","year":"1995","journal-title":"Vaccine"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/00006454-198910000-00006","article-title":"Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: Immunogenicity and reactogenicity","volume":"8","author":"Ho","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0035-9203(91)90061-3","article-title":"Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine","volume":"85","author":"Jalil","year":"1991","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0264-410X(86)90135-0","article-title":"Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00152704","article-title":"Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine","volume":"4","author":"Giammanco","year":"1988","journal-title":"Eur. J. Epidemiol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1542\/peds.2009-1021","article-title":"Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States","volume":"125","author":"Boom","year":"2010","journal-title":"Pediatrics"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.vaccine.2013.03.072","article-title":"Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs","volume":"31","author":"Donauer","year":"2013","journal-title":"Vaccine"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4161\/hv.7.7.15576","article-title":"Effectiveness of rotavirus vaccination in Spain","volume":"7","author":"Sonia","year":"2011","journal-title":"Hum. Vaccines"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/cid\/civ1206","article-title":"A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia","volume":"62","author":"Beres","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/ciw014","article-title":"Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana","volume":"62","author":"Armah","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/infdis\/jiw023","article-title":"A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants","volume":"213","author":"Armah","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"A129","DOI":"10.1016\/j.vaccine.2014.03.002","article-title":"Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants","volume":"32","author":"Kompithra","year":"2014","journal-title":"Vaccine"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/INF.0b013e3181715170","article-title":"Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India","volume":"27","author":"Ramani","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4161\/hv.22341","article-title":"Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants","volume":"9","author":"Lokeshwar","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/infdis\/jiu335","article-title":"Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: A randomized trial","volume":"210","author":"Ali","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_315","first-page":"92","article-title":"Intestinal intussusception in children: A review of 70 cases","volume":"19","author":"Rattan","year":"2000","journal-title":"Indian J. Gastroenterol. Off. J.Indian Soc. Gastroenterol."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/02724936.1992.11747555","article-title":"Intussusception in children under 2 years of age in the State of Qatar: Analysis of 67 cases","volume":"12","author":"Dawod","year":"1992","journal-title":"Ann. Trop. Paediatr."},{"key":"ref_317","unstructured":"World Health Organization (WHO) (2002). Acute Intussusception in Infants and Children: Incidence, Clinical Representation and Management: A Global Perspective, World Health Organization."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jpeds.2006.04.010","article-title":"Risk factors for intussusception in infants in Vietnam and Australia: Adenovirus implicated, but not rotavirus","volume":"149","author":"Bines","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_319","doi-asserted-by":"crossref","unstructured":"Jiang, J., Jiang, B., Parashar, U., Nguyen, T., Bines, J., and Patel, M.M. (2013). Childhood intussusception: A literature review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068482"},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s National Immunization Program","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.vaccine.2016.04.050","article-title":"The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation","volume":"34","author":"Stowe","year":"2016","journal-title":"Vaccine"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/00006454-199810000-00018","article-title":"Lack of an apparent association between intussusception and wild or vaccine rotavirus infection","volume":"17","author":"Rennels","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_323","first-page":"734","article-title":"Intussusception in infancy and childhood: Analysis of 69 cases","volume":"70","author":"Mangete","year":"1993","journal-title":"East. African Med. J."},{"key":"ref_324","first-page":"403","article-title":"Intussusception","volume":"65","author":"Sutthiwan","year":"1982","journal-title":"J. Med. Assoc. Thailand Chotmaihet Thangphaet"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/j.1536-4801.1987.tb09380.x","article-title":"Intussusception: Evolution of current management","volume":"6","author":"Bruce","year":"1987","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00006454-199810000-00009","article-title":"Viral etiology of intussusception in Taiwanese childhood","volume":"17","author":"Hsu","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPG.0b013e3181d3273f","article-title":"Sociodemographic and Dietary Risk Factors for Natural Infant Intussusception in the United States","volume":"51","author":"Johnson","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_328","unstructured":"Centers for Disease Control and Prevention (1999). Intussusception among recipients of rotavirus vaccine\u2014United States, 1998\u20131999. MMWR. Morb. Mortal. Wkly. Rep., 48, 577."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1542\/peds.108.1.54","article-title":"Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York State","volume":"108","author":"Chang","year":"2001","journal-title":"Pediatrics"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0140-6736(01)06346-2","article-title":"Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception","volume":"358","author":"Simonsen","year":"2001","journal-title":"Lancet"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1542\/peds.2012-2554","article-title":"Intussusception after rotavirus vaccines reported to US VAERS, 2006\u20132012","volume":"131","author":"Haber","year":"2013","journal-title":"Pediatrics"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1080\/21645515.2016.1197452","article-title":"Rotavirus vaccination and intussusception\u2014Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries","volume":"12","author":"Yen","year":"2016","journal-title":"Hum. Vaccine Immunother."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/154.11.1006","article-title":"Enhancing Vaccine Safety Surveillance: A Capture-Recapture Analysis of Intussusception after Rotavirus Vaccination","volume":"154","author":"Verstraeten","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/02724936.2000.11748122","article-title":"Childhood intussusception: A 9-year review","volume":"20","author":"Ugwu","year":"2000","journal-title":"Ann. Trop. Paediatr."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpeds.2015.03.038","article-title":"Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study","volume":"167","author":"Yung","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/infdis\/jis314","article-title":"Trends in Intussusception Hospitalizations Among US Infants Before and After Implementation of the Rotavirus Vaccination Program, 2000\u20132009","volume":"206","author":"Yen","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0378-1135(94)00136-K","article-title":"Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material","volume":"44","author":"Allan","year":"1995","journal-title":"Vet. Microbiol."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01314286","article-title":"Studies on epidemiology and pathogenicity of porcine circovirus","volume":"91","author":"Tischer","year":"1986","journal-title":"Arch. Virol."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1128\/JVI.02690-09","article-title":"Viral nucleic acids in live-attenuated vaccines: Detection of minority variants and an adventitious virus","volume":"84","author":"Victoria","year":"2010","journal-title":"J. Virol."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1016\/j.vaccine.2011.04.087","article-title":"Molecular and infectivity studies of porcine circovirus in vaccines","volume":"29","author":"McClenahan","year":"2011","journal-title":"Vaccine"},{"key":"ref_341","unstructured":"Martin\u00f3n-Torres, F., Vesikari, T., Giaquinto, C., and Huppertz, H.-I. (2015, January 23\u201325). How France reversed its position on rotavirus vaccination - Presented by Pierre Pothier. Proceedings of the 4th European Expert Meeting on Rotavirus Vaccination (EEROVAC), Santiago de Compostela, Spain."},{"key":"ref_342","first-page":"431","article-title":"Porcine circovirus antigens in PK-15 cell line (ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs","volume":"53","author":"Dulac","year":"1989","journal-title":"Can. J. Vet. Res."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1751-0813.2005.tb12747.x","article-title":"The detection of porcine circovirus in the Australian pig herd","volume":"83","author":"Raye","year":"2005","journal-title":"Aust. Vet. J."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/104063879801000102","article-title":"Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe","volume":"10","author":"Allan","year":"1998","journal-title":"J. Vet. Diagn. Invest."},{"key":"ref_345","first-page":"635","article-title":"The double-edged sword: How evolution can make or break a live-attenuated virus vaccine","volume":"4","author":"Hanley","year":"2011","journal-title":"Evolution (N Y)"},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jis361","article-title":"Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination","volume":"206","author":"Donato","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/INF.0000000000000221","article-title":"Detection of rotateq vaccine-derived, double-reassortant rotavirus in a 7-year-old child with acute gastroenteritis","volume":"33","author":"Hemming","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3201\/eid1911.121407","article-title":"Evidence of vaccine-related reassortment of rotavirus, Brazil, 2008\u20132010","volume":"19","author":"Rose","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/infdis\/jis490","article-title":"Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: A case series","volume":"206","author":"Boom","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.meegid.2014.05.020","article-title":"Characterization of G2P[4] rotavirus strains associated with increased detection in Australian states using the RotaTeq (R) vaccine during the 2010\u20132011 surveillance period","volume":"28","author":"Donato","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.meegid.2014.08.017","article-title":"Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: Is there evidence of strain selection from vaccine pressure?","volume":"28","author":"Martella","year":"2014","journal-title":"Infect. Genet. Evol."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/j.vaccine.2007.02.052","article-title":"Freezing temperatures in the vaccine cold chain: A systematic literature review","volume":"25","author":"Matthias","year":"2007","journal-title":"Vaccine"},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1016\/j.vaccine.2007.06.065","article-title":"An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh","volume":"25","author":"Levin","year":"2007","journal-title":"Vaccine"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1016\/j.vaccine.2015.08.085","article-title":"Freeze-drying of live virus vaccines: A review","volume":"33","author":"Hansen","year":"2015","journal-title":"Vaccine"},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.vaccine.2019.03.067","article-title":"Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL\u2014Liquid) in Indian infants","volume":"37","author":"Kawade","year":"2019","journal-title":"Vaccine"},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(98)12106-2","article-title":"Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: A randomised placebo-controlled trial","volume":"354","author":"Bernstein","year":"1999","journal-title":"Lancet"},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00006454-199804000-00013","article-title":"Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants","volume":"17","author":"Joensuu","year":"1998","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/infdis\/jiy197","article-title":"The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data","volume":"218","author":"Kirkwood","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/23744235.2016.1275773","article-title":"Rotavirus epidemiology 5\u20136 years after universal rotavirus vaccination: Persistent rotavirus activity in older children and elderly","volume":"49","author":"Markkula","year":"2017","journal-title":"Infect. Dis."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1099\/jgv.0.000352","article-title":"Emergence of a novel equine-like G3P[8] inter-genogroup reassortant rotavirus strain associated with gastroenteritis in Australian children","volume":"97","author":"Cowley","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/S1679-45082016RB3582","article-title":"Group A rotavirus gastroenteritis: Post-vaccine era, genotypes and zoonotic transmission","volume":"14","author":"Luchs","year":"2016","journal-title":"Einstein (Sao Paulo)"},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"18585","DOI":"10.1038\/srep18585","article-title":"Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium?","volume":"5","author":"Pitzer","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/infdis\/jir390","article-title":"Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico","volume":"204","author":"Yen","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1473-3099(14)70940-5","article-title":"Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: A case-control study","volume":"14","author":"Groome","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"e4752","DOI":"10.1136\/bmj.e4752","article-title":"Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: Case-control study","volume":"345","author":"Braeckman","year":"2012","journal-title":"BMJ"},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1016\/j.vaccine.2018.03.035","article-title":"Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008\u20132015","volume":"36","author":"Simwaka","year":"2018","journal-title":"Vaccine"},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1016\/j.vaccine.2017.11.068","article-title":"Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction","volume":"36","author":"Seheri","year":"2018","journal-title":"Vaccine"},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4269\/ajtmh.1986.35.1013","article-title":"The Detection of Enteropathogens in Acute Diarrhea in a Family Cohort Population in Rural Egypt","volume":"35","author":"Zaki","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(14)70832-1","article-title":"Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: A systematic review and meta-analysis","volume":"14","author":"Leshem","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/INF.0b013e3181fefd78","article-title":"United States rotavirus strain surveillance from 2005 to 2008: Genotype prevalence before and after vaccine introduction","volume":"30","author":"Hull","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/INF.0b013e3181fefd90","article-title":"Distribution of Rotavirus Genotypes After Introduction of Rotavirus Vaccines, Rotarix\u00ae and RotaTeq\u00ae, into the National Immunization Program of Australia","volume":"30","author":"Kirkwood","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1016\/j.vaccine.2010.09.004","article-title":"Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium","volume":"28","author":"Zeller","year":"2010","journal-title":"Vaccine"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2217\/fmb.09.96","article-title":"Rotavirus disease and vaccination: Impact on genotype diversity","volume":"4","author":"Matthijnssens","year":"2009","journal-title":"Future Microbiol."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/gbe\/evv157","article-title":"Genome-Wide Evolutionary Analyses of G1P[8] Strains Isolated Before and After Rotavirus Vaccine Introduction","volume":"7","author":"Zeller","year":"2015","journal-title":"Genome Biol. Evol."},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/infdis\/164.2.277","article-title":"Protection from rotavirus reinfection: 2-year prospective study","volume":"164","author":"Bernstein","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1080\/21645515.2016.1179412","article-title":"Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination","volume":"12","author":"Steele","year":"2016","journal-title":"Hum. Vaccine Immunother."},{"key":"ref_378","doi-asserted-by":"crossref","unstructured":"Cunliffe, N., Zaman, K., Rodrigo, C., Debrus, S., Benninghoff, B., Pemmaraju Venkata, S., and Han, H.H. (2014). Early exposure of infants to natural rotavirus infection: A review of studies with human rotavirus vaccine RIX4414. BMC Pediatr., 14.","DOI":"10.1186\/s12887-014-0295-2"},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/314504","article-title":"The Protective Effectiveness of Natural Rotavirus Infection in an American Indian Population","volume":"178","author":"Moulton","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/infdis\/169.4.900","article-title":"Protection against Rotavirus Disease after Natural Rotavirus Infection","volume":"169","author":"Ward","year":"1994","journal-title":"J. Infect. Dis."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1086\/342294","article-title":"Protective immunity after natural rotavirus infection: A community cohort study of newborn children in Guinea-Bissau, west Africa","volume":"186","author":"Fischer","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/148.3.452","article-title":"Epidemiology of Rotaviruses in a Cohort of 45 Guatamalan Mayan Indian Children Observed from Birth to the Age of Three Years","volume":"148","author":"Mata","year":"1983","journal-title":"J. Infect. Dis."},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1128\/jcm.27.9.2083-2090.1989","article-title":"Prospective study of community-acquired rotavirus infection","volume":"27","author":"Zheng","year":"1989","journal-title":"J. Clin. Microbiol."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00006454-199706000-00006","article-title":"Rotavirus infections in young Nicaraguan children","volume":"16","author":"Espinoza","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/oxfordjournals.aje.a010080","article-title":"Epidemiology of Rotavirus Diarrhea in Egyptian Children and Implications for Disease Control","volume":"150","author":"Naficy","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/oxfordjournals.aje.a115431","article-title":"An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observation","volume":"130","author":"Reves","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa1006261","article-title":"Protective effect of natural rotavirus infection in an Indian birth cohort","volume":"365","author":"Gladstone","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/infdis\/168.2.282","article-title":"Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea","volume":"168","author":"Bhan","year":"1993","journal-title":"J. Infect. Dis."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/infdis\/174.Supplement_1.S30","article-title":"Review of G and P typing results from a global collection of rotavirus strains: Implications for vaccine development","volume":"174","author":"Gentsch","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/jcm.30.4.781-785.1992","article-title":"Distribution of serotypes of human rotavirus in different populations","volume":"30","author":"Woods","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1128\/jcm.33.6.1516-1519.1995","article-title":"Geographic distribution of human rotavirus VP4 genotypes and VP7 serotypes in five South African regions","volume":"33","author":"Steele","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/JCM.38.1.264-267.2000","article-title":"Genotype profiles of rotavirus strains from children in a suburban community in Guinea-Bissau, Western Africa","volume":"38","author":"Fischer","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/jcm.34.2.436-439.1996","article-title":"Unusual diversity of human rotavirus G and P genotypes in India","volume":"34","author":"Ramachandran","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/tropej\/42.4.207","article-title":"Diversity of rotavirus strains infecting pediatric patients in New Delhi, India","volume":"42","author":"Chatterjee","year":"1996","journal-title":"J. Trop. Pediatr."},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1128\/jcm.32.5.1408-1409.1994","article-title":"Rotavirus serotype G5 associated with diarrhea in Brazilian children","volume":"32","author":"Gouvea","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/BF01718637","article-title":"Rotavirus G and P types circulating in Brazil: Characterization by RT-PCR, probe hybridization, and sequence analysis","volume":"141","author":"Leite","year":"1996","journal-title":"Arch. Virol."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890470102","article-title":"Relative frequency of human rotavirus VP4 (P) genotypes recovered over a ten-year period from South African children with diarrhea","volume":"47","author":"Mphahlele","year":"1995","journal-title":"J. Med. Virol."},{"key":"ref_398","unstructured":"Global Alliance for Vaccines and Immunizations (GAVI) (2016). GAVI Alliance Secures Lower Price for Rotavirus Vaccine, GAVI."},{"key":"ref_399","unstructured":"Global Alliance for Vaccines and Immunizations (GAVI) (2017). Vaccine Pricing: Gavi Transitioning Countries, WHO."},{"key":"ref_400","unstructured":"Maggie, F. (2020, May 08). Childhood Vaccination Plunge Since Covid-19 Pandemic Started, CDC Says. Available online: https:\/\/edition.cnn.com\/2020\/05\/08\/health\/childhood-vaccines-cdc--covid-wellness\/index.html."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/341\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:43:31Z","timestamp":1760175811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":400,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["vaccines8030341"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8030341","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,27]]}}}